Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering

Core Viewpoint - Nanalysis Scientific Corp. has successfully closed the second tranche of its $3.4 million non-brokered private placement, raising an additional $921,795 through the issuance of 6,145,300 units at a price of $0.15 per unit [1][2]. Group 1: Offering Details - The total number of units issued under the Offering amounts to 22,671,583 [2]. - Each unit consists of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of an additional share at an exercise price of $0.20, valid for two years from the closing date [3]. - The warrants include an acceleration provision that allows the company to shorten the expiry date if the share price exceeds $0.30 for 10 consecutive trading days [3]. Group 2: Financial Aspects - The company paid a total of $2,000 in cash commissions as finder's fees related to the second tranche of the Offering [4]. - The Offering is subject to final acceptance by the TSX Venture Exchange, and all securities issued are subject to a statutory hold period of four months and one day [4]. Group 3: Company Overview - Nanalysis Scientific Corp. specializes in developing and manufacturing portable Nuclear Magnetic Resonance (NMR) spectrometers, which are utilized across various industries including pharmaceuticals, biotechnology, energy, food, materials, and security [6]. - The company also operates a services division that maintains its own products and third-party imaging equipment, supported by a $160 million long-term contract with the Canadian Air Transport Security Authority to maintain security scanners at over 80 Canadian airports [6].